Global Pet Vaccine Market Growth 2025-2031

The global Pet Vaccine market size is predicted to grow from US$ 4032 million in 2025 to US$ 6176 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.

Pet vaccines are biological preparations designed to stimulate an immune response in pets, protecting them from infectious diseases caused by viruses, bacteria, and other pathogens. These vaccines help prevent severe illnesses such as rabies, distemper, parvovirus, and feline leukemia, reducing mortality rates and improving the overall health of companion animals. Vaccination is a crucial aspect of preventive veterinary care and is commonly administered to dogs, cats, and other domesticated animals based on specific vaccination schedules.

With advancements in veterinary medicine, modern pet vaccines are becoming more effective, safer, and tailored to specific breeds and regional disease risks. Innovations such as recombinant vaccines and mRNA-based vaccines are enhancing immune responses with fewer side effects. As pet ownership rises globally and awareness of animal health increases, the demand for high-quality pet vaccines continues to grow, supporting both public health and animal welfare.

Market Drivers:

The pet vaccine market is primarily driven by the increasing pet ownership worldwide and a growing awareness of animal health and preventive care. As more people adopt pets, the demand for vaccines to protect them from infectious diseases rises, especially with the expansion of the pet care industry. Moreover, advancements in veterinary vaccines, including more effective and safer vaccines, are improving vaccination outcomes and encouraging wider use. Public health initiatives and regulations, such as rabies vaccination requirements, also play a role in fueling market growth. Additionally, rising disposable incomes, particularly in emerging markets, are enabling pet owners to spend more on veterinary care, including vaccinations.

Market Challenges:

One of the major challenges facing the pet vaccine market is the high cost of some vaccines, which can be a barrier to regular vaccination, especially for pet owners in lower-income regions. Furthermore, the increasing complexity of vaccine schedules and the need for specialized veterinary care may slow down adoption rates in some areas. In addition, the emergence of counterfeit or low-quality vaccines poses a significant threat to market growth and animal health. Regulatory barriers and inconsistencies across different regions can also hinder the efficient distribution and accessibility of vaccines, especially in emerging markets with less-developed veterinary infrastructure.

LP Information, Inc. (LPI) ' newest research report, the “Pet Vaccine Industry Forecast” looks at past sales and reviews total world Pet Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Vaccine sales for 2025 through 2031. With Pet Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Pet Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Nasal Administration
Injection
Other

Segmentation by Application:
Cat
Dog
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
CAHIC
Ringpu
Jinyu Group
Keqian Biology
Kyoritsu Seiyaku

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pet Vaccine market?

What factors are driving Pet Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pet Vaccine market opportunities vary by end market size?

How does Pet Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.